Rad24 Inhibitors

Rad24-Inhibitors predominantly target proteins and pathways central to DNA damage response and the cell cycle. Rad24, by virtue of its regulatory role in these processes, can be indirectly influenced by agents acting on its associated pathways.

For instance, ATR kinase is integral to the DNA damage response, especially during replication stress. Inhibitors such as VE-821 and AZD6738 that target ATR kinase can inadvertently affect Rad24's function within the same pathway. Similarly, the ATM kinase, target of KU-55933, also plays a role in DNA damage signaling and overlaps with Rad24's sphere of action. Further along the pathway, CHK1, a direct target of MK-8776 and UCN-01, operates in synchrony with Rad24. An impediment to CHK1's function can thereby influence the broader DNA damage response involving Rad24. Agents like Roscovitine, which inhibit cyclin-dependent kinases, can perturb the cell cycle machinery, indirectly involving Rad24. The DNA repair landscape is incomplete without mentioning PARP, a target of Olaparib. By influencing DNA repair mechanisms, Olaparib can impact pathways that Rad24 participates in. Similarly, DNA synthesis inhibitors such as Mimosine, Hydroxyurea, and Aphidicolin can indirectly impinge upon Rad24's functional domain.